Daptomycin and Aplastic anemia - a phase IV clinical study of FDA data

Summary:

Aplastic anemia is reported as a side effect among people who take Daptomycin (daptomycin), especially for people who are male, 60+ old, also take Envarsus Xr, and have Graft versus host disease.

The phase IV clinical study analyzes which people have Aplastic anemia when taking Daptomycin. It is created by eHealthMe based on reports of 7,865 people who have side effects when taking Daptomycin from the FDA, and is updated regularly.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.

What is Aplastic anemia?

Aplastic anemia is found to be associated with 621 drugs and 886 conditions by eHealthMe. Check the latest studies of Aplastic anemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

7,865 people reported to have side effects when taking Daptomycin.
Among them, 15 people (0.19%) have Aplastic anemia.

Among these 15 people:

What is the gender of people who have Aplastic anemia when taking Daptomycin? *

female: 20 %
male: 80 %

What is the age of people who have Aplastic anemia when taking Daptomycin? *

What are other drugs people take besides Daptomycin? *

What are other side effects people have besides Aplastic anemia? *

Thrombocytopenia (decrease of platelets in blood): 11 people, 73.33%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 11 people, 73.33%
Chimerism (fertilization of two separate ova by two sperm): 11 people, 73.33%
Cytomegalovirus Infection: 11 people, 73.33%
Diarrhea: 11 people, 73.33%
Enteritis (inflammation of the small intestine): 11 people, 73.33%
Enterococcal Infection: 11 people, 73.33%
Haemoglobin Decreased: 11 people, 73.33%
Systemic Inflammatory Response Syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection): 11 people, 73.33%
Leukopenia (less number of white blood cells in blood): 11 people, 73.33%

What are the existing conditions these people have? *

Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 11 people, 73.33%
Cytomegalovirus Infection: 3 people, 20.00%
Staphylococcal Infection (an infection with staphylococcus bacteria): 2 people, 13.33%
Opsoclonus Myoclonus (a rare neurological disorder of unknown causes which appears to be the result of an autoimmune process involving the nervous system): 1 person, 6.67%
Movement - Uncoordinated: 1 person, 6.67%
Immunodeficiency Disorders: 1 person, 6.67%
Fever: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Daptomycin and have Aplastic anemia?

- Check whether Aplastic anemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Daptomycin:

Daptomycin (7,879 reports)

Aplastic anemia treatments and more:

Aplastic anemia (14,870 reports)

Browse all side effects of Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aplastic anemia:

Aplastic anemia (621 drugs)

Browse all the conditions that are associated with Aplastic anemia:

Aplastic anemia (886 conditions)

Related publications that referenced our studies

Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .
Saliho?lu M, Turhan V, ?nem Y, Ulcay A, Uzun G, Ay H, "Sudden hearing loss in a patient receiving piperacillin/tazobactam and daptomycin for diabetic foot infection", Scandinavian journal of infectious diseases, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on daptomycin (the active ingredients of Daptomycin) and Daptomycin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.